Literature DB >> 7365285

Identification of the activator system for antibody to Toxoplasma as the classical complement pathway.

R D Schreiber, H A Feldman.   

Abstract

In view of the many recent advances in our understanding of the composition and function of the complement system, it was decided to apply this newer knowledge to an investigation of the heat-labile activator required for the action of antibody to Toxoplasma gondii in the neutralization and dye tests. With use of antibody-coated toxoplasma trophozoites in a diluent of 0.2% gelatin in 0.85% NaCl and alkaline methylene blue as indicator, various component-deficient sera were added to activate the antibody on the protozoan membranes. It was determined that the classical complement system is required for antibody activity and that the properdin system plays no role in the reaction. Human sera genetically deficient in C5, C6, C7, and C8 were shown to be inactive as activators of antibody to Toxoplasma. The addition of specific missing components immediately restored full activity to the deficient sera.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7365285     DOI: 10.1093/infdis/141.3.366

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Toxoplasma gondii-specific immunoglobulin M limits parasite dissemination by preventing host cell invasion.

Authors:  Kevin N Couper; Craig W Roberts; Frank Brombacher; James Alexander; Lawrence L Johnson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T cells.

Authors:  V Duquesne; C Auriault; F Darcy; J P Decavel; A Capron
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  Immunoglobulin M-dependent classical complement pathway activation in killing of Pentatrichomonas hominis.

Authors:  M F Shaio; J G Chen
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Cerebral complement C1q activation in chronic Toxoplasma infection.

Authors:  Jianchun Xiao; Ye Li; Kristin L Gressitt; Helen He; Geetha Kannan; Tracey L Schultz; Nadezhda Svezhova; Vern B Carruthers; Mikhail V Pletnikov; Robert H Yolken; Emily G Severance
Journal:  Brain Behav Immun       Date:  2016-04-22       Impact factor: 7.217

5.  Specific and nonspecific mediation of protective immunity to Toxoplasma gondii.

Authors:  L Reyes; J K Frenkel
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

6.  B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii.

Authors:  P C Sayles; G W Gibson; L L Johnson
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Activation of the alternative and classical complement pathways by Entamoeba histolytica.

Authors:  J Calderon; R D Schreiber
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

8.  CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis.

Authors:  Fangli Lu; Shiguang Huang; Lloyd H Kasper
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice.

Authors:  S J Parker; C W Roberts; J Alexander
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

10.  Immunoenzymatic detection of three kinds of 43,000-molecular-weight antigens by monoclonal antibodies in the insoluble fraction of Toxoplasma gondii.

Authors:  K Ogata; T Kasahara; K Shioiri-Nakano; I Igarashi; M Suzuki
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.